NEW YORK (GenomeWeb) – PerkinElmer said today that it has inked a definitive agreement to acquire Lübeck, Germany-based Euroimmun Medical Laboratory Diagnostics for about $1.3 billion in cash.

Euroimmun is recognized as a global leader in autoimmune testing and an emerging force in infectious disease and allergy testing, and has "extensive expertise and capabilities" across immunology, cell biology, histology, biochemistry, and molecular biology, PerkinElmer said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.